Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • F-star Therapeutics (NASDAQ:FSTX) stock increased by 70.8% to $6.8 during Thursday's pre-market session. The market value of their outstanding shares is at $146.5 million.
  • Redhill Biopharma (NASDAQ:RDHL) stock increased by 39.57% to $1.07. The company's market cap stands at $56.9 million. As per the news, the Q1 earnings report came out today.
  • Jasper Therapeutics (NASDAQ:JSPR) stock rose 20.8% to $2.09. The company's market cap stands at $79.1 million.
  • Synlogic (NASDAQ:SYBX) stock rose 19.46% to $1.35. The company's market cap stands at $94.8 million.
  • Amryt Pharma (NASDAQ:AMYT) stock moved upwards by 16.78% to $8.0. The market value of their outstanding shares is at $513.1 million.
  • Clene (NASDAQ:CLNN) shares rose 15.69% to $2.8. The market value of their outstanding shares is at $177.1 million.

Losers

  • Applied Therapeutics (NASDAQ:APLT) shares fell 21.5% to $0.84 during Thursday's pre-market session. The company's market cap stands at $22.0 million.
  • Zai Lab (NASDAQ:ZLAB) stock decreased by 10.88% to $29.0. The market value of their outstanding shares is at $2.8 billion.
  • Clovis Oncology (NASDAQ:CLVS) shares declined by 10.46% to $1.37. The company's market cap stands at $197.1 million.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares decreased by 9.04% to $0.42. The market value of their outstanding shares is at $11.2 million.
  • Aptevo Therapeutics (NASDAQ:APVO) stock declined by 6.65% to $3.65. The company's market cap stands at $18.2 million.
  • Quotient (NASDAQ:QTNT) stock fell 6.33% to $0.4. The company's market cap stands at $41.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.